Company Taiwan Liposome Company, Ltd.

Equities

4152

TW0004152004

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Bio Therapeutic Drugs

Inactive Instrument

Taiwan Liposome Company, Ltd. is a Taiwan-based company principally engaged in the research and development and commercialization of lipid drug delivery systems. The Company is engaged in the development of special generic drugs, new formulas and new drugs using patents. The Company's therapeutic areas include pain management, eye diseases and cancer. Its anticancer medicine product named Lipo-Dox has been distributed in domestic and Asian markets.

Number of employees: 161

Managers	Title	Age	Since
Chih Hung Yeh CEO	Chief Executive Officer	52	02-02-28
Kee Lung Hong CHM	Chairman	81	97-11-09

Members of the board	Title	Age	Since
Mao Jung Lin BRD	Director/Board Member	69	17-05-30
Kee Lung Hong CHM	Chairman	81	97-11-09
Chih Hung Yeh CEO	Chief Executive Officer	52	02-02-28
Chan Yue Li BRD	Director/Board Member	52	14-06-17
Jaemin Kim David BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	84,155,000	23,625,268 ( 28.07 %)	0	28.07 %

Taiwan Liposome Co., Ltd.

11/F-1 No. 3, Yuanqu Street

115 03, Taipei

+886 2 2655 7377

http://www.tlcbio.com

address Taiwan Liposome Company, Ltd.(4152)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.20%	104B
REGENERON PHARMACEUTICALS, INC.	+1.96%	97.42B
ARGENX SE	+0.96%	22.2B
BIONTECH SE	-18.01%	21.23B
GENMAB A/S	-11.02%	18.33B
WUXI APPTEC CO., LTD.	-42.33%	16.35B
BEIGENE, LTD.	-18.01%	15.06B
NEUROCRINE BIOSCIENCES, INC.	+5.35%	13.98B
SAREPTA THERAPEUTICS, INC.	+27.24%	11.66B

Bio Therapeutic Drugs